FDA label 62e208c2-8745-47bf-bacc-8f64d67f8d0d

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID: ea5c93e2-a8b5-4d89-a6e2-d31a6c01c7b8
SPL ID: 62e208c2-8745-47bf-bacc-8f64d67f8d0d
Version: 1
Effective date: 2017-06-23
Source export date: 2026-09-28
Source partition: 10
Source file: https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/4bbc9760f647649b787710953d978bd6419e899ba8b90f32c3d972aae43947f8/drug-label-0010-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:10:11

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 2 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
spl id		62e208c2-8745-47bf-bacc-8f64d67f8d0d	id
spl set id		ea5c93e2-a8b5-4d89-a6e2-d31a6c01c7b8	set_id

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only. Avoid contact with eyes & lip, if contact occurs, flush throoughly with water . Ask a doctor or pharmacist before using other topical acne medications at the same time or immediately following use of this product. May increase dryness or irritation of the skin. If this occurs, only one medication should be usedunless directed by a doctor. When using this product apply to affected area only. Do not use on broken skin or apply to large areas of the body.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.